CPA
CHRS icon

Capital Performance Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Capital Performance Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,117
Closed -$2.2K – 638
2024
Q3 		$2.2K Buy
+2,117
New +$2.2K ﹤0.01% 1515